Falnidamol and cisplatin combinational treatment inhibits non-small cell lung cancer (NSCLC) by targeting DUSP26-mediated signal pathways
Zihan Cui, Dapeng Li, Jun Zhao, Kai Chen
Topics & Concepts
CisplatinApoptosisCancer researchLung cancerEpidermal growth factor receptorDNA damageCell cycle checkpointCell growthReactive oxygen speciesCell cycleCytotoxicityCombination therapyPharmacologyProgrammed cell deathCancerChemistryBiologyMedicineChemotherapyOncologyIn vitroInternal medicineDNABiochemistryFerroptosis and cancer prognosisDrug Transport and Resistance MechanismsHistone Deacetylase Inhibitors Research